BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17030851)

  • 1. Human papillomaviruses target the double-stranded RNA protein kinase pathway.
    Hebner CM; Wilson R; Rader J; Bidder M; Laimins LA
    J Gen Virol; 2006 Nov; 87(Pt 11):3183-3193. PubMed ID: 17030851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
    Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
    Strickland SW; Vande Pol S
    J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
    Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
    Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
    Yablonska S; Hoskins EE; Wells SI; Khan SA
    Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
    Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
    Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
    Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
    Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
    mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.
    Kazemi S; Papadopoulou S; Li S; Su Q; Wang S; Yoshimura A; Matlashewski G; Dever TE; Koromilas AE
    Mol Cell Biol; 2004 Apr; 24(8):3415-29. PubMed ID: 15060162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
    Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.
    Bienkowska-Haba M; Luszczek W; Zwolinska K; Scott RS; Sapp M
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31748387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.
    Hong S; Mehta KP; Laimins LA
    J Virol; 2011 Sep; 85(18):9486-94. PubMed ID: 21734056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.
    Moody CA; Laimins LA
    PLoS Pathog; 2009 Oct; 5(10):e1000605. PubMed ID: 19798429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.
    Sudarshan SR; Schlegel R; Liu X
    Biochem Biophys Res Commun; 2010 Sep; 399(4):617-22. PubMed ID: 20688044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.
    Thomas JT; Hubert WG; Ruesch MN; Laimins LA
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8449-54. PubMed ID: 10411895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
    J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.